Pawlotsky Jean-Michel
Department of Virology, INSERM U635, Hôpital Henri Mondor, Unioersité Paris 12, Créteil, France. jean-michel.pawlotskyhmn.aphp.fr
J Clin Virol. 2005 Dec;34 Suppl 1:S125-9. doi: 10.1016/s1386-6532(05)80021-6.
Hepatitis B virus (HBV) reverse transcriptase is an error-prone enzyme, and this results in a large number of nucleotide substitutions during replication. As a result, HBV has a "quasispecies" distribution in infected individuals, meaning that HBV circulates as a complex mixture of genetically distinct but closely related variants that are in equilibrium at a given time point of infection in a given replicative environment. The quasispecies distribution of HBV implies that any newly generated mutation conferring a selective advantage to the virus in a given replicative environment will allow the corresponding viral population to overtake the other variants. Such selection processes occur at any step of infection to allow the emergence of variant viruses, such as precore and core promoter mutants during the natural course of infection, HBs antigen mutants under the pressure of active or passive anti-HBs immunization, or HBV mutants that are resistant to the antiviral action of specific HBV inhibitors.
乙型肝炎病毒(HBV)逆转录酶是一种易出错的酶,这导致在复制过程中出现大量核苷酸替换。因此,HBV在受感染个体中呈“准种”分布,这意味着HBV以基因上不同但密切相关的变体的复杂混合物形式循环,这些变体在给定复制环境中感染的给定时间点处于平衡状态。HBV的准种分布意味着,在给定复制环境中赋予病毒选择性优势的任何新产生的突变,将使相应的病毒群体超过其他变体。这种选择过程发生在感染的任何阶段,以允许变体病毒出现,例如在自然感染过程中的前核心和核心启动子突变体、在主动或被动抗HBs免疫压力下的HBs抗原突变体,或对特定HBV抑制剂的抗病毒作用具有抗性的HBV突变体。